Skip to main content
Ikonisys S.A. logo

Ikonisys S.A. — Investor Relations & Filings

Ticker · ALIKO ISIN · FR00140048X2 LEI · 9695000B742KPNDQ4D05 PA Manufacturing
Open in API
Filings indexed 193 across all filing types
Latest filing 2023-12-28 Share Issue/Capital Cha…
Country FR France
Listing PA ALIKO

About Ikonisys S.A.

https://www.ikonisys.com

Ikonisys S.A. is a cell-based diagnostics company specializing in Fluorescence in Situ Hybridization (FISH) technology for genetic analysis. The company develops, manufactures, and markets integrated solutions that include proprietary automated microscopy instruments, advanced software, and reagents. These systems are designed to improve efficiency, accuracy, and standardization for pathologists and laboratory technicians. Ikonisys's technology enables the precise detection and analysis of chromosomal alterations, supporting early and accurate cancer diagnosis, prognosis, and the selection and monitoring of personalized therapies. The platform's automation and digitization features streamline the entire workflow from image acquisition to quantitative interpretation for oncology and genetic testing applications.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated December 28, 2023, announcing that Ikonisys SA has successfully raised 1 M€ through a private placement ('placement privé'). The text details the purpose of the funds (accelerating growth, supporting distribution agreements) and provides a detailed breakdown of the capital increase ('Augmentation de Capital'), including the number of new shares issued and the resulting dilution for existing shareholders. This clearly falls under the category of announcing fundraising or capital structure changes. Reviewing the definitions: - 10-K/IR: Not a full annual or interim financial report. - ER: Not an earnings release, but a financing announcement. - The core subject is the successful completion of a capital raise/private placement. - The most fitting category is 'Capital/Financing Update' (CAP), as it explicitly discusses the issuance of new shares to raise capital.
2023-12-28 French
Inside Information / Other news releases
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated December 28, 2023, announcing that Ikonisys SA has successfully completed a private placement to raise €1 million. The text details the use of proceeds, legal terms of the capital increase, the issuance price, and the impact on shareholding structure. This activity—raising capital through the issuance of new shares via a private placement—falls directly under the definition of a 'Capital/Financing Update'. Therefore, the appropriate code is CAP.
2023-12-28 English
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a press release dated December 15, 2023, announcing a new partnership between Ikonisys, Hospitex International, and the Pathologists Beyond Borders Association (APOF). It details the strategic goals of this collaboration. This type of announcement, which communicates a significant business development (a partnership) but is not a formal regulatory filing like a 10-K, earnings release (ER), or a capital change (CAP), fits best under the general category for corporate news or regulatory announcements that don't have a more specific code. Since it is a general corporate announcement about a business development, and not a specific financial report, management change, or insider trade, the most appropriate classification among the provided options is 'Regulatory Filings' (RNS) as a general corporate announcement/press release, or potentially 'LTR' if it were legal/regulatory action, but partnership announcements usually fall under general news. Given the options, RNS serves as the best general corporate announcement fallback, although it is not a standard regulatory filing in the SEC sense, it is a public disclosure. However, upon reviewing the definitions, none perfectly capture a 'Partnership Announcement'. Since it is a press release detailing business operations and strategy updates, and not a formal financial report, it is closest to a general corporate disclosure. I will classify it as RNS (Regulatory Filings) as the general catch-all for corporate news releases that don't fit the specific financial/governance codes.
2023-12-15 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release from Ikonisys SA announcing a partnership between Hospitex International and the Association des médecins pathologistes sans frontières (APOF). It details a strategic collaboration, quotes executives, and provides 'About Us' sections for the involved entities. This type of announcement, which communicates a significant business development or strategic alliance, does not fit the specific definitions for financial reports (10-K, IR, ER), regulatory filings (RNS, DVA), or specific corporate actions (DIV, CAP, POS). It is a general corporate announcement. Since there is no specific category for 'Partnership Announcement' or 'Press Release', the most appropriate fallback category is 'Regulatory Filings' (RNS), as press releases often serve as the primary means of disseminating non-mandated, material information to the market, or it could be considered a general corporate update. Given the options, RNS is the best fit for a general, non-financial, non-management change announcement that is not a specific report.
2023-12-15 French
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated November 30, 2023, announcing a definitive agreement for Ikonisys SA to acquire 100% of Hospitex International. The text details the strategic rationale, financial terms (payment via new share issuance), potential earn-outs, and the impact on share capital structure. This type of announcement, detailing a significant corporate transaction like an acquisition, falls under the category of M&A Activity (TAR). It is a substantive announcement, not just a notice of publication (RPA) or a general regulatory filing (RNS).
2023-11-30 French
Inside Information / Operations of the issuer (acquisitions, sales...)
M&A Activity Classification · 99% confidence The document is a press release dated November 30, 2023, announcing that Ikonisys SA has entered into an agreement to acquire 100% of Hospitex International. The text details the strategic rationale, the consideration (€4.5 million via share issuance), lock-up commitments, and theoretical impacts on share capital. This type of announcement, detailing a significant corporate transaction (acquisition/merger), directly corresponds to the M&A Activity category. It is not a standard periodic report (10-K, IR, ER) or a simple announcement of a report release (RPA).
2023-11-30 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.